Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-03-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||
net income | -978,428,000 | -539,432,000 | -366,171,000 | -643,390,000 | -680,859,000 | -653,766,000 | -630,894,000 | -764,232,000 | -779,528,000 | -472,648,000 | -530,101,000 | -220,425,000 | -81,286,000 | -1,045,680,000 | -871,798,158 | -156,614 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||
depreciation and amortization | 120,090,000 | 111,088,000 | 97,959,000 | 66,183,000 | 68,838,000 | 67,498,000 | 60,832,000 | 55,363,000 | 49,838,000 | 55,240,000 | 50,653,000 | 42,448,000 | 38,242,000 | 36,286,000 | ||
amortization of insurance premium | 9,536,000 | 8,571,000 | 8,914,000 | 8,725,000 | 8,589,000 | 9,265,000 | 9,114,000 | 10,865,000 | 10,263,000 | 10,432,000 | 10,264,000 | 7,425,000 | 7,499,000 | 11,290,000 | ||
non-cash operating lease cost | 12,928,000 | 11,207,000 | 8,551,000 | 7,667,000 | 7,469,000 | 7,330,000 | 6,593,000 | 6,448,000 | 5,830,000 | 5,457,000 | 5,302,000 | 4,848,000 | 4,104,000 | 3,934,000 | ||
stock-based compensation | 115,055,000 | 56,319,000 | 27,515,000 | 57,013,000 | 63,696,000 | 63,851,000 | 68,237,000 | 71,376,000 | 53,819,000 | 71,255,000 | 83,302,000 | 94,392,000 | 174,551,000 | 150,557,000 | ||
inventory and firm purchase commitments write-downs | 190,664,000 | 179,888,000 | 147,918,000 | 145,243,000 | 132,298,000 | 171,574,000 | 230,816,000 | 276,631,000 | 227,048,000 | 204,926,000 | ||||||
change in fair value of common stock warrant liability | -444,000 | -5,322,000 | -12,861,000 | -7,539,000 | -27,054,000 | -25,279,000 | -60,316,000 | -42,133,000 | 40,802,000 | -255,899,000 | -140,146,000 | -334,843,000 | -523,330,000 | 557,973,000 | ||
change in fair value of equity securities of a related party | -916,000 | -3,948,000 | 13,453,000 | 9,390,000 | 19,933,000 | |||||||||||
change in fair value of derivative liabilities associated with redeemable convertible preferred stock | 36,375,000 | -111,475,000 | -281,700,000 | |||||||||||||
net accretion of investment discounts/premiums | -2,616,000 | -5,582,000 | -13,480,000 | -23,004,000 | -21,304,000 | |||||||||||
gain on extinguishment of debt | 0 | |||||||||||||||
other non-cash items | 719,000 | 6,582,000 | 2,718,000 | 6,199,000 | -1,255,000 | 81,195,000 | -19,286,000 | -8,654,000 | -19,050,000 | -5,322,000 | -5,015,000 | |||||
changes in operating assets and liabilities: | ||||||||||||||||
accounts receivable | -13,263,000 | -35,041,000 | 21,781,000 | 25,584,000 | -75,196,000 | -28,731,000 | -2,800,000 | -17,987,000 | 17,009,000 | -16,987,000 | -1,119,000 | -673,000 | 2,281,000 | -2,887,000 | ||
inventory | -446,557,000 | -379,573,000 | -206,470,000 | -62,408,000 | -21,002,000 | -82,077,000 | -127,971,000 | -93,808,000 | -354,154,000 | -350,295,000 | -302,202,000 | -300,830,000 | -303,022,000 | -114,979,000 | ||
prepaid expenses | -4,366,000 | -20,254,000 | -7,423,000 | -8,227,000 | -11,042,000 | -2,579,000 | -12,027,000 | -21,953,000 | -9,082,000 | -16,721,000 | -18,560,000 | -14,064,000 | 20,523,000 | -1,283,000 | ||
other assets | ||||||||||||||||
accounts payable | 185,815,000 | 58,890,000 | -377,000 | 6,714,000 | -3,533,000 | -24,709,000 | -18,811,000 | -29,825,000 | -66,174,000 | 128,253,000 | 2,620,000 | 43,883,000 | 5,713,000 | 18,529,000 | ||
other liabilities | ||||||||||||||||
net cash from operating activities | -756,650,000 | -830,241,000 | -428,613,000 | -506,987,000 | -516,745,000 | -474,549,000 | -513,582,000 | -700,358,000 | -801,264,000 | -648,515,000 | -569,466,000 | -513,628,000 | -494,649,000 | -312,732,000 | ||
capex | -198,818,000 | -182,663,000 | -194,152,000 | -289,089,000 | -157,733,000 | -272,642,000 | -192,517,000 | -203,715,000 | -261,582,000 | -289,888,000 | -290,064,000 | 0 | -185,082,000 | -121,907,000 | ||
free cash flows | -955,468,000 | -1,012,904,000 | -622,765,000 | -796,076,000 | -674,478,000 | -747,191,000 | -706,099,000 | -904,073,000 | -1,062,846,000 | -938,403,000 | -859,530,000 | -513,628,000 | -679,731,000 | -434,639,000 | ||
cash flows from investing activities: | ||||||||||||||||
purchases of property, plant and equipment | -198,818,000 | -182,663,000 | -161,241,000 | -234,315,000 | -198,197,000 | -272,642,000 | -192,517,000 | -203,715,000 | -241,770,000 | -289,888,000 | -290,064,000 | |||||
purchases of investments | 0 | -22,528,000 | -287,029,000 | -1,339,579,000 | -514,548,000 | -413,028,000 | -1,438,001,000 | -1,304,715,000 | -842,538,000 | -1,127,452,000 | -1,307,454,000 | |||||
proceeds from maturities of investments | 451,968,000 | 899,194,000 | 1,062,291,000 | 1,257,603,000 | 1,030,291,000 | 1,240,320,000 | 498,081,000 | 941,338,000 | 1,041,151,000 | 1,024,361,000 | ||||||
proceeds from sale of investments | 0 | 0 | 135,144,000 | 13,244,000 | ||||||||||||
other investing activities | 0 | 0 | ||||||||||||||
net cash from investing activities | 255,118,000 | 694,003,000 | 614,021,000 | -311,291,000 | 317,546,000 | 652,150,000 | -1,132,437,000 | -437,972,000 | -28,716,000 | -392,656,000 | -1,374,898,000 | -1,729,041,000 | -185,082,000 | -121,399,000 | ||
cash flows from financing activities: | ||||||||||||||||
proceeds from issuance of series a redeemable convertible preferred stock to a related party | ||||||||||||||||
proceeds from issuance of series b redeemable convertible preferred stock to a related party | ||||||||||||||||
payments of issuance costs for series a redeemable convertible preferred stock | ||||||||||||||||
payments of issuance costs for series b redeemable convertible preferred stock | ||||||||||||||||
proceeds from issuance of common stock under 2025 subscription agreement | ||||||||||||||||
payment of issuance costs for the 2025 subscription agreement | ||||||||||||||||
proceeds from issuance of 2030 notes | 0 | |||||||||||||||
payment of transaction costs for the issuance of 2030 notes | -166,000 | |||||||||||||||
purchase of capped call options | 0 | |||||||||||||||
repurchase of 2026 notes | 0 | |||||||||||||||
proceeds from borrowings from a related party | 79,976,000 | 39,989,000 | 66,656,000 | |||||||||||||
repayment of borrowings to a related party | ||||||||||||||||
proceeds from exercise of stock options | 626,000 | 861,000 | 413,000 | 786,000 | 1,525,000 | 3,022,000 | 2,214,000 | 2,926,000 | 2,181,000 | 3,050,000 | 1,889,000 | 3,735,000 | 9,114,000 | 2,105,000 | ||
proceeds from employee stock purchase plan | 0 | 8,747,000 | 0 | 11,680,000 | 0 | |||||||||||
tax withholding payments for net settlement of employee awards | -3,060,000 | -6,172,000 | -3,277,000 | -2,070,000 | -3,242,000 | -2,910,000 | -4,327,000 | -3,879,000 | -6,499,000 | |||||||
payment for finance lease liabilities | -1,046,000 | -822,000 | -554,000 | -848,000 | -1,081,000 | -891,000 | -1,455,000 | -1,652,000 | -1,427,000 | -1,372,000 | -1,204,000 | -1,200,000 | -1,201,000 | -1,173,000 | ||
payment for credit facility issuance costs | 0 | 0 | ||||||||||||||
net cash from financing activities | 376,052,000 | 78,945,000 | 62,731,000 | 2,363,000 | 997,202,000 | 27,959,000 | 35,086,000 | 3,013,615,000 | -5,745,000 | 1,512,801,000 | 17,643,000 | 4,092,000 | -187,301,000 | 1,899,585,000 | ||
net increase in cash, cash equivalents, and restricted cash | -125,480,000 | -57,293,000 | 248,139,000 | -815,915,000 | 798,003,000 | 471,630,000 | -867,032,000 | 1,465,454,000 | ||||||||
beginning cash, cash equivalents, and restricted cash | 0 | 0 | 1,607,052,000 | 0 | 1,371,507,000 | 0 | 0 | 0 | 1,737,320,000 | 0 | 0 | 0 | 6,298,020,000 | 0 | ||
ending cash, cash equivalents, and restricted cash | -125,480,000 | -57,293,000 | 1,855,191,000 | -815,915,000 | 2,169,510,000 | 205,560,000 | -1,610,933,000 | 1,875,285,000 | 901,595,000 | 471,630,000 | -1,926,721,000 | -2,238,577,000 | 5,430,988,000 | 1,465,454,000 | ||
other current assets | -32,874,000 | 45,299,000 | -26,224,000 | 3,914,000 | -8,922,000 | -4,808,000 | -3,705,000 | 22,193,000 | -10,329,000 | -1,063,000 | 17,426,000 | -49,625,000 | -23,003,000 | |||
other noncurrent assets | -22,338,000 | -45,911,000 | -19,023,000 | -4,369,000 | -8,000,000 | -4,032,000 | -82,421,000 | -27,337,000 | -4,148,000 | -11,526,000 | ||||||
other current liabilities | 1,076,000 | 116,845,000 | -36,320,000 | -3,040,000 | -27,675,000 | -625,000 | -50,591,000 | 7,211,000 | -12,159,000 | 102,001,000 | ||||||
other long-term liabilities | 8,337,000 | 14,827,000 | 52,697,000 | 19,025,000 | 49,454,000 | 5,644,000 | 16,009,000 | 4,340,000 | 10,837,000 | 12,396,000 | 5,894,000 | 1,901,000 | -9,870,000 | |||
payment for credit facility issuance costs to a related party | 0 | -507,000 | ||||||||||||||
supplemental disclosure of cash flow information: | ||||||||||||||||
cash paid for interest, net of amounts capitalized | 4,321,000 | 10,556,000 | 1,031,000 | 10,450,000 | 857,000 | |||||||||||
cash paid for taxes | 33,000 | 9,000 | ||||||||||||||
supplemental disclosure of non-cash investing and financing activity: | ||||||||||||||||
increases (decreases) in purchases of property, plant and equipment included in accounts payable and other current liabilities | -32,911,000 | -54,774,000 | 40,464,000 | |||||||||||||
government grant (related party) reflected in property, plant and equipment | ||||||||||||||||
property, plant and equipment and right-of-use assets obtained through leases | 27,813,000 | 3,065,000 | 4,327,000 | 17,705,000 | 3,862,000 | |||||||||||
proceeds from government grant | 0 | |||||||||||||||
proceeds from issuance of common stock under 2024 underwriting agreement, net of issuance costs | ||||||||||||||||
proceeds from issuance of common stock under 2024 subscription agreement to a related party, net of issuance costs | ||||||||||||||||
proceeds from issuance of common stock under 2023 underwriting agreement, net of issuance costs | ||||||||||||||||
proceeds from issuance of common stock under 2023 subscription agreement to a related party, net of issuance costs | ||||||||||||||||
proceeds from issuance of common stock under at-the-market offering, net of issuance costs | ||||||||||||||||
proceeds from issuance of common stock under 2022 subscription agreement to a related party | ||||||||||||||||
payment for short-term insurance financing note | 0 | 0 | -2,381,000 | -12,949,000 | -11,068,000 | |||||||||||
proceeds from failed sale-leaseback transaction | 0 | |||||||||||||||
increases | ||||||||||||||||
equity securities obtained through strategic technology arrangement | ||||||||||||||||
change in fair value of derivative liability associated with series a redeemable convertible preferred stock | ||||||||||||||||
accrued compensation | 36,733,000 | 8,147,000 | 30,953,000 | -7,460,000 | -15,866,000 | 21,545,000 | 14,314,000 | -6,542,000 | 26,793,000 | -3,607,000 | 3,415,000 | |||||
proceeds from issuance of common stock under underwriting agreement, net of issuance costs | 0 | 0 | ||||||||||||||
repayment of borrowings from a related party | ||||||||||||||||
proceeds from issuance of redeemable convertible preferred stock to a related party | 1,000,000,000 | |||||||||||||||
change in fair value of contingent forward contract liability | 0 | |||||||||||||||
change in fair value of preferred stock warrant liability | 0 | |||||||||||||||
change in fair value of equity securities | ||||||||||||||||
proceed from issuance of convertible notes, net of issuance costs | ||||||||||||||||
payment of transaction costs for the issuance of convertible notes | ||||||||||||||||
proceeds from issuance of common stock under 2023 subscription agreement, net of issuance costs | 0 | 0 | ||||||||||||||
proceeds from issuance of common stock under 2022 subscription agreement | ||||||||||||||||
proceeds from short-term insurance financing note | 0 | |||||||||||||||
proceeds from borrowings | 19,991,000 | 38,654,000 | 9,590,000 | 13,565,000 | ||||||||||||
repayments for borrowings | -13,570,000 | |||||||||||||||
repurchase of series b convertible preferred stock | 0 | |||||||||||||||
proceeds from issuance of series d convertible preferred stock | 0 | |||||||||||||||
proceeds from issuance of series e convertible preferred stock | 0 | |||||||||||||||
proceeds from the exercise of public warrants | 0 | |||||||||||||||
proceeds from the reverse capitalization | ||||||||||||||||
payment of transaction costs related to the reverse recapitalization | -34,054,000 | |||||||||||||||
treasury stock repurchase | ||||||||||||||||
net decrease in cash, cash equivalents, and restricted cash | 205,560,000 | -835,725,000 | ||||||||||||||
purchases of property, plant and equipment included in accounts payable and other current liabilities | ||||||||||||||||
issuance of series d convertible preferred stock upon exercise of preferred stock warrants | ||||||||||||||||
issuance of series e convertible preferred stock contingent forward contracts | ||||||||||||||||
capital contribution upon forfeit of series e awards | ||||||||||||||||
issuance of series e convertible preferred stock upon settlement of contingent forward contracts | ||||||||||||||||
issuance of common stock upon conversion of preferred stock in connection with the reverse recapitalization | ||||||||||||||||
operating lease liabilities | -5,788,000 | |||||||||||||||
supplemental disclosure of non-cash investing and financing activities: | ||||||||||||||||
cash flows from operating activities | ||||||||||||||||
operating lease liability | -5,837,000 | -4,721,000 | -3,817,000 | -3,845,000 | -3,099,000 | -5,503,000 | ||||||||||
proceeds from insurance claims | 1,197,000 | |||||||||||||||
decrease in purchases of property, plant and equipment included in accounts payable and other current liabilities | -19,812,000 | |||||||||||||||
proceeds from sale of property, plant and equipment | ||||||||||||||||
proceeds from sale of short term investments | ||||||||||||||||
proceeds from issuance of common stock under subscription agreement | ||||||||||||||||
payment for capital lease liabilities | ||||||||||||||||
repurchase of series c convertible preferred stock | ||||||||||||||||
stock repurchases from employees for tax withholdings | -5,894,000 | -21,654,000 | -8,976,000 | -182,265,000 | ||||||||||||
amortization of debt discounts and issuance costs | 1,154,000 | 1,255,000 | ||||||||||||||
inventory write-downs | ||||||||||||||||
proceed from sale of property, plant and equipment | ||||||||||||||||
loss on disposal of property and equipment | -4,000 | |||||||||||||||
write-down of inventory | 96,366,000 | |||||||||||||||
other noncurrent assets and security deposit | -11,175,000 | 11,750,000 | ||||||||||||||
other liabilities and accrued liabilities | 128,060,000 | 47,622,000 | ||||||||||||||
purchases of property, equipment, and software | -185,082,000 | -121,907,000 | ||||||||||||||
cash paid for interest | 312,000 | |||||||||||||||
property and equipment included in accounts payable and accrued expense | -2,753,000 | |||||||||||||||
property and equipment and right-of-use assets obtained through leases | 10,008,000 | |||||||||||||||
amortization of debt discount | ||||||||||||||||
financed insurance premium | 0 | |||||||||||||||
proceed from sale of property, equipment, and software | 3,000 | |||||||||||||||
proceeds from the reverse recapitalization | 0 | |||||||||||||||
issuance of series d convertible preferred stock upon settlement of contingent forward contracts | ||||||||||||||||
transaction costs related to the reverse recapitalization not yet paid | ||||||||||||||||
| ||||||||||||||||
change in fair value of derivative liabilities | ||||||||||||||||
interest expense - excess fair value of conversion liability | ||||||||||||||||
interest earned on marketable securities held in trust account | ||||||||||||||||
prepaid expenses and other current assets | ||||||||||||||||
accounts payable and accrued expenses | ||||||||||||||||
income taxes payable | ||||||||||||||||
proceeds from issuance of class b common stock to sponsor | ||||||||||||||||
proceeds from promissory note – related party | ||||||||||||||||
payment of convertible promissory note – related party | ||||||||||||||||
net cash from used in financing activities | ||||||||||||||||
net change in cash | ||||||||||||||||
cash – beginning of period | ||||||||||||||||
cash – ending of period | ||||||||||||||||
non-cash investing and financing activities: | ||||||||||||||||
offering costs included in accrued offering costs | ||||||||||||||||
change in value of class a common stock subject to possible redemption | ||||||||||||||||
initial classification of conversion option liability | ||||||||||||||||
class a common stock subject to possible redemption | ||||||||||||||||
numerator: earnings allocable to class a common stock subject to possible redemption | ||||||||||||||||
interest income | 177,326 | |||||||||||||||
unrealized gain on investments held in trust account | 3,956 | |||||||||||||||
less: company’s portion available to be withdrawn to pay taxes | -73,578 | |||||||||||||||
less: company’s portion available to be withdrawn for working capital purposes | -107,704 | |||||||||||||||
net income allocable to class a common stock subject to possible redemption | ||||||||||||||||
denominator: weighted-average class a common stock subject to possible redemption | ||||||||||||||||
basic and diluted weighted-average shares outstanding, class a common stock subject to possible redemption | 196,306,266 | |||||||||||||||
basic and diluted net income per share, class a common stock subject to possible redemption | 0 | |||||||||||||||
non-redeemable common stock | ||||||||||||||||
numerator: net income minus net earnings | ||||||||||||||||
less: income allocable to class a common stock subject to possible redemption | ||||||||||||||||
non-redeemable net income | -871,798,158 | |||||||||||||||
denominator: weighted-average non-redeemable common stock | ||||||||||||||||
basic and diluted weighted-average shares outstanding, non-redeemable common stock | 65,318,734 | |||||||||||||||
basic and diluted net income per share, non-redeemable common stock | -13.35 | |||||||||||||||
less: income attributable to shares subject to possible redemption | ||||||||||||||||
adjusted net income | -156,614 | |||||||||||||||
weighted-average shares outstanding, basic and diluted | 51,122,554 | |||||||||||||||
basic and diluted net income per common share | 0 | |||||||||||||||
less: net income allocable to class a common stock subject to possible redemption |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
